AstraZeneca launches Eculizumab in India EP News Bureau Sep 10, 2025 It is now the first anti-complement therapy authorised in India for the treatment of for atypical Haemolytic Uremic Syndrome(aHUS)…
AstraZeneca India launches Eculizumab to treat aHUS and PNH EP News Bureau Sep 9, 2025 AstraZeneca India, a leading global biopharmaceutical company has launched Eculizumab concentrate solution for infusion (300 mg,10…
CDSCO approves AstraZeneca’s anti-complement medicine Eculizumab EP News Bureau Jan 17, 2025 Eculizumab is approved in India to manage two rare diseases- Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic…
